Furthermore, there is a limited number of studies in Asia, and to the best of our knowledge, this is the first study that further suggests the need to stratify the indeterminate group of patients by assessing their clinical parameters, such as serum gamma‐glutamyl transpeptidase (GGT) level and presence of diabetes mellitus. This evidence concerns the gene GGTLC1 and diabetes mellitus.